CLDX CELLDEX THERAPEUTICS INC NEW

Ownership history in Walleye Trading LLC  ·  27 quarters on record

This page tracks every 13F SEC filing in which Walleye Trading LLC reported a position in CELLDEX THERAPEUTICS INC NEW (CLDX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 2,400 -3,300 -57.9% 0.00% $62K $25.87
2025 Q3 REDUCED 5,700 -5,900 -50.9% 0.00% $147K $25.87
2023 Q4 ADDED 11,600 +7,000 +152.2% 0.00% $460K $39.66
2023 Q4 REDUCED 4,600 -9,479 -67.3% 0.00% $182K $39.66
2023 Q4 ADDED 14,079 +13,079 +1307.9% 0.00% $558K $39.66
2023 Q3 REDUCED 1,000 -7,330 -88.0% 0.00% $28K $27.52
2023 Q3 ADDED 8,330 +7,530 +941.2% 0.00% $229K $27.52
2023 Q3 REDUCED 800 -7,738 -90.6% 0.00% $22K $27.52
2023 Q2 ADDED 8,538 +6,938 +433.6% 0.00% $290K $33.93
2023 Q2 ADDED 1,600 +100 +6.7% 0.00% $54K $33.93
17 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CLDX price (monthly, adj. close)
← Back to Walleye Trading LLC Holdings